Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/SBTX stock hub

AIM/SBTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/SBTXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

25.3M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/SBTX

In the news

Latest news · AIM/SBTX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-11.2

P25 -54.2P50 2.1P75 13.7

ROIC-9.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/SBTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

GBP

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	41
Employees Change	26%
Employees Change Percent	173.3
Enterprise value	GBX 21.5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BF33H870
Last refreshed	2026-05-10
Market cap	GBX 25.3M
Price	GBX 9.75
Price currency	GBX
Rev Per Employee	113,125.54x
Sector	Healthcare
Sic	2844
Symbol	aim/SBTX
Website	https://www.skinbiotherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.76%
EV Earnings	-30.86x
EV/FCF	-17.31x
EV/Sales	4.63x
FCF yield	-4.91%
P/B ratio	2.68x
P/S ratio	5.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.22%
EBITDA Margin	-17.65%
Gross margin	61.65%
Gross Profit	GBX 2.9M
Gross Profit Growth	91.59%
Gross Profit Growth Q	222.33%
Gross Profit Growth3 Y	204.1%
Gross Profit Growth5 Y	102.64%
Net Income	GBX -696,253
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	-15.42%
Profit Margin	-15.01%
Profit Per Employee	GBX -16,982
ROA	-8.1
Roa5y	-36.98
ROCE	-10.54
ROE	-11.24
Roe5y	-72.78
ROIC	-9.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.4%
Cagr3y	-18.1%
Cagr5y	-27.3%
EPS Growth Quarters	5
EPS Growth Years	3
Revenue Growth	283.74x
Revenue Growth Q	177.8x
Revenue Growth Quarters	6x
Revenue Growth Years	3x
Revenue Growth3 Y	206.14x
Revenue Growth5 Y	104.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.53
Assets	GBX 12.1M
Cash	GBX 4.8M
Current Assets	GBX 7.1M
Current Liabilities	GBX 1.5M
Debt	GBX 993,466
Debt Equity	GBX 0.11
Debt FCF	GBX -0.8
Equity	GBX 9.4M
Interest Coverage	-12.21
Liabilities	GBX 2.7M
Long Term Assets	GBX 5M
Long Term Liabilities	GBX 1.2M
Net Cash	GBX 3.8M
Net Cash By Market Cap	GBX 14.98
Net Debt Equity	GBX -0.4
Tangible Book Value	GBX 5.1M
Tangible Book Value Per Share	GBX 0.02
WACC	5.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.84
Inventory Turnover	2.8
Net Working Capital	GBX 971,681
Quick ratio	4.21
Working Capital	GBX 5.6M
Working Capital Turnover	GBX 1.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.38%
200-day SMA	15.06
3Y total return	-45.07%
50-day SMA	12.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.69%
All Time High	88
All Time High Change	-88.92%
All Time High Date	2021-05-26
All Time Low	5
All Time Low Change	95%
All Time Low Date	2020-03-27
ATR	1.68
Beta	0.13
Beta1y	-1.78
Beta2y	-0.81
Ch YTD	-38.1
High	11
High52	27.5
High52 Date	2025-04-25
High52ch	-64.55%
Low	9.5
Low52	5
Low52 Date	2026-03-23
Low52ch	95%
Ma50ch	-22.45%
Price vs 200-day SMA	-35.24%
RSI	48.65
RSI Monthly	41.78
RSI Weekly	43.49
Sharpe ratio	-0.32x
Sortino ratio	-0.34
Total Return	-22.32%
Tr YTD	-38.1
Tr1m	4.61%
Tr1w	24.2%
Tr3m	-38.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -1.1M
Operating margin	-24.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	148,028,237%
Net Borrowing	842,473
Shares Insiders	38.84%
Shares Institutions	59.68%
Shares Out	259,168,671
Shares Qo Q	4.35%
Shares Yo Y	22.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -1.2M
Average Volume	2,063,207.85x
Bv Per Share	0.04
CAPEX	GBX -6,300
Ch1m	4.61
Ch1w	24.2
Ch1y	-59.38
Ch3m	-38.49
Ch3y	-45.07
Ch5y	-79.69
Ch6m	-35.54
Change	-4.88%
Change From Open	-6.97
Close	10.25
Days Gap	2.24
Depreciation Amortization	304,389
Dollar Volume	20,417,406.8
Earnings Date	2026-06-23
EBIT	GBX -1.1M
EBITDA	GBX -818,746
EPS	GBX -0
F Score	4
FCF	GBX -1.2M
FCF EV Yield	-5.78x
FCF Per Share	GBX -0
Financing CF	6,834,959
Fiscal Year End	June
Founded	2,015
Goodwill	2,419,640
Income Tax	GBX -18,863
Investing CF	-1,621,360
Is Primary Listing	1
Last Earnings Date	2026-01-07
Last Report Date	2025-06-30
Ma150	14.72
Ma150ch	-33.78%
Ma20	9.78
Ma20ch	-0.32%
Net CF	3,978,529
Next Earnings Date	2026-06-23
Open	10.48
Position In Range	16.67
Ppne	728,348
Price Date	2026-03-31
Ptbv Ratio	4.93
Relative Volume	1.01x
Revenue	4,638,147x
Tax By Revenue	-0.41x
Tr6m	-35.54%
Volume	2,094,093
Z Score	7.36

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/SBTX pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/SBTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/SBTX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+59.7%

Share of float held by funds and institutions

Insider ownership

+38.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+22.3%

Negative means the company is buying back shares.

Technical

AIM/SBTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.6

Neutral momentum band

Price vs 200-day MA

-35.2%

50/200-day relationship not available

Beta (5Y)

0.13

Less volatile than the market

Sharpe ratio

-0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/SBTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/SBTX stock rating?

aim/SBTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/SBTX analysis?

The full report lives at /stocks/aim/SBTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/SBTX?

The latest report frames aim/SBTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/SBTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.